Polatuzumab vedotin in relapsed or refractory diffuse large B-cell lymphoma
- Laurie H. Sehn
- , Alex F. Herrera
- , Christopher R. Flowers
- , Manali K. Kamdar
- , Andrew McMillan
- , Mark Hertzberg
- , Sarit Assouline
- , Tae Min Kim
- , Won Seog Kim
- , Muhit Ozcan
- , Jamie Hirata
- , Elicia Penuel
- , Joseph N. Paulson
- , Ji Cheng
- , Grace Ku
- , Matthew J. Matasar
- University of British Columbia
- City of Hope National Med Center
- Emory University
- University of Colorado Anschutz Medical Campus
- Nottingham University Hospitals NHS Trust
- University of New South Wales
- McGill University
- Seoul National University
- Ankara University
- Genentech, Inc
- F. Hoffman-La Roche
- Memorial Sloan-Kettering Cancer Center
Research output: Contribution to journal › Article › peer-review
680
Link opens in a new tab
Scopus
citations